Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ashley Cordova currently holds 437,569 shares of NovoCure Ltd (NVCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ashley Cordova has been a net seller of NVCR stock. They have purchased $996.5K and sold $5.1M worth of shares.
Ashley Cordova's most recent insider trade was on Sep 5, 2025, when they purchased 81,550 shares at $12.22 per share.
Ashley Cordova serves as Executive at NovoCure Ltd (NVCR). They have executed 54 insider transactions totaling $6.1M over their tenure at the company.
Ashley Cordova holds the position of Executive at NovoCure Ltd, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Ashley Cordova has shown a selling trading pattern, with $996.5K in total purchases and $5.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ashley Cordova was on Feb 27, 2024, when they purchased $2.5M worth of NVCR shares. This transaction involved 156,348 shares at $16.30 per share.
Ashley Cordova currently owns 437,569 shares of NovoCure Ltd (NVCR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ashley Cordova's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ashley Cordova has 54 Form 4 filings on record as an insider at NovoCure Ltd.
Set alerts for Ashley Cordova and 40,000+ other insiders.